🔎 Trials Near Me

Početna › Liposarkom › Missouri

Kliničke studije za Liposarkom u državi Missouri

5 studija za Liposarkom traži sudionike na lokacijama u državi Missouri.

Gradovi u državi Missouri

Službeni tekst studije (engleski)

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06422806

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

  • Siteman Cancer Center-West County, Creve Coeur
  • Washington University School of Medicine - Siteman Cancer Center, St Louis
  • Siteman Cancer Center-South Country, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT04031677

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT05711615

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Washington University Medical Center, St Louis
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06239272

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.